Back to search

University of Patras

Μελέτη της έκφρασης παραγόντων αγγειογένεσης σε σχέση με την απόπτωση και το βαθμό κακοήθειας στο αδενοκαρκίνωμα του προστάτη: ο ρόλος κλειδί της κυκλοοξυγενάσης-2

Abstract

dc:description

The aim of this study was to immunohistochemically evaluate the expression of VEGF-A, FGF-2, COX-2, AR and BCL-2 in benign prostatic hyperplasia (BPH) and prostate carcinoma in relation to microvessel density (MVD) and the Gleason grade of the neoplasms. A total of 139 cases of primary prostate carcinoma and 24 cases of benign hyperplasia were included in the study. Tumors were graded according to the Gleason grading system and further divided into 3 subgroups (GRADE I, II and III). The immunostaining was performed according to the Streptavidin-Biotin Complex Peroxidase method, in formalin fixed paraffin-embedded tissue. Mean micro vessel density (MVD) was strongly related to tumor grade, VEGF-A and COX-2 histoscore (ANOVA, p<0.001). The androgen receptor was localized in the nuclei of prostate epithelial cells in 97% of cases. The comparison of AR staining with tumor grade revealed an inverse relationship between these two parameters (ANOVA, p<0,0001). An interesting finding was the inverse relationship of stromal AR expression in relation to VEGF-A immunoreactivity. BCL-2 expression was correlated with tumor grade in prostate carcinoma cases (p<0.001) and was strongly correlated with COX-2 and VEGF-A expression (p<0.001). These findings suggest that BCL-2 may play a dual role in tumorigenesis, possibly through an angiogenetic axis. VEGF-A expression was detected in only 17% of BPH cases but all prostate cancer specimens demonstrated some degree of immunoreactivity. COX-2 immunopositivity was present in 54% of BPH specimens and in 99% of primary prostate carcinomas. The increased COX-2 expression correlated significantly with Gleason grade. In our study, high-grade neoplasms presented low to moderate VEGF staining intensity compared to COX-2 expression. These results suggest the activation of an angiogenic switch in poorly differentiated neoplasms, where COX-2 may play a crucial role compared to VEGF and the possible key role of COX-2 in poorly differentiated cancers. According to our findings, anti-VEGF therapy could prove to be more beneficial in patients with low-grade disease, while patients with high-grade prostate carcinoma are more likely to respond to selective COX-2 inhibitors. Immunohistochemical determination of VEGF-A and COX-2 content might prove a useful tool in the design of patient-tailored, anti-angiogenic treatments.

Degree

thesis:*
Grantor dc:publisher
University of Patras
Year dc:date
2009

Author and committee

dc:creator, dc:contributor.*
Authors dc:creator
  • Vourda, Kate
  • Βούρδα, Αικατερίνη

Subjects

dc:subject × 16

Rights

Language dc:language
gre

Identifiers

dc:identifier.*
Identifier
10.12681/eadd/17671

Chain of custody

source
Harvested from
Greek National Archive of PhD Theses
Base URL
phdtheses.ekt.gr/eadd_oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Vourda, Kate; Βούρδα, Αικατερίνη. Μελέτη της έκφρασης παραγόντων αγγειογένεσης σε σχέση με την απόπτωση και το βαθμό κακοήθειας στο αδενοκαρκίνωμα του προστάτη: ο ρόλος κλειδί της κυκλοοξυγενάσης-2. University of Patras, 2009. http://hdl.handle.net/10442/hedi/17671